Cytokinetics Inc. buy JPMorgan Chase & Co.
Start price
17:30
/
50%
€64.42
Target price
13.08.27
€89.38
Performance (%)
1.30%
Price
18:19
€65.26
Summary
This prediction is currently active. With a performance of 1.30%, the BUY prediction by JPMorgan_Chase___Co_ for Cytokinetics Inc. is trending in the right direction. This prediction currently runs until 13.08.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Cytokinetics Inc. | 1.30% |
| iShares Core DAX® | 0.625% |
| iShares Nasdaq 100 | 1.160% |
| iShares Nikkei 225® | 2.356% |
| iShares S&P 500 | 0.631% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (CYTK) had its price target raised by JPMorgan Chase & Co. from $97.00 to $103.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.00
09.06.25
09.06.25
€46.41
09.06.26
09.06.26
101.52%
10.06.26
10.06.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€50.50
05.09.24
05.09.24
€63.96
05.09.25
05.09.25
-9.31%
06.09.25
06.09.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€49.60
24.06.24
24.06.24
€60.52
24.06.25
24.06.25
-42.74%
25.06.25
25.06.25